Leonard Kaps

MD Phd, Cinical Scientist, Biochemist

[Leonard Kaps @kaps_leonard]

We tested nanoparticle formulated alendronate to achieve a high drug load in liver for antifibrotic treatment:
"pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages"
https://t.co/a6aeaqq5dS

[The Baveno Cooperation: an EASL Consortium @BavenoCoop]

💉 Albumin duration & AKI response in cirrhosis
Eva M. Schleicher (Mainz) – #EASL2025
🕒 24h albumin new rule questioned
🏆 EASL AKI response definition wins
📈 20% of 24h NR improved at 48h
⚖️ Early vs late responders: Same mortality
🚨 Cr ↑ >16% @24h → terlipressin!
👇

[Eva Maria Schleicher @EvSchleicher]

Thanks Baveno for highlighting this important topic! ☔️🌂

[Jonathan G. Stine, MD MSc, FACP @JonathanStineMD]

@VilarinhoSilvia @ggarciatsao Such a great group! Can’t believe it’s been 7 years! @ZGordonJiang @Drfattyliver @AjmeraVeeral @kaps_leonard @GSzaboMD

[Gastroenterology Advisor @Gastro_Advisor]

Incorporating the use of the Clinical Frailty Scale in clinical practice can help to identify patients with cirrhosis who may be at a higher risk of developing hepatic encephalopathy. @EvSchleicher @kaps_leonard @schattenbergJ @SJGairing #GItwitter

https://t.co/dTT1r7sGIx

[Eric Trépo @etrepo]

🔍 Evaluating the annual risk of #HCC based on underlying liver disease @NatRevClinOncol
Do these numbers for ALD/MASLD reflect your clinical practice? 🤔 Please vote👇
#livertwitter @juanpabloarab @ArndtVogel @BCLC_group @maximeronot @NaultJc @jnkath @ma5RN @rabataller @EASLedu

[Tesla @Tesla]

Tesla Full Self-Driving capability demo in Austin

FSD capability features use vision neural networks to perceive & understand the world, just like humans do.

Via our unique fleet learning approach, we are able to collect anonymized data from our vehicles—meaning the neural nets have learned from a few orders of magnitude more driving scenarios than the average human driver (including unusual & weird ones!)

[tagesschau @tagesschau]

Liveblog: ++ Israels Militär erwartet schwere Verluste ++ https://t.co/IQ5XzB8610 #Israel #Liveblog

[CLabenz @c_labenz]

@JasmohanBajaj @AGA_CGH @ebtapper @BloomPringle @DebbieShawcros1 @BrainLIverPS @ISHENliver @SahajRathi @VCU_Liver @VAResearch @RichmondVAMC Congrats @JasmohanBajaj and team! You bring MHE testing into the real world. Time for validation in different parts of the world @MMLauridsen @ISHENliver

[CLabenz @c_labenz]

Extremely proud of these two rising stars of hepatology @EvSchleicher and Henrike Dobbermann. Both won important prizes at the #DGVS congress 2023! @jumarquardt @UnimedizinMainz @UKSH_KI_HL

[Leonard Kaps @kaps_leonard]

Masterclass Reunion of 2017
#EASL #AASLD #liver #conference
Nice to see you again

[Leonard Kaps @kaps_leonard]

Masterclass Reunion of 2017
#EASL #AASLD #liver #conference
Nice to see you again

[Leonard Kaps @kaps_leonard]

Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV https://t.co/1VzqQV1p98

[Leonard Kaps @kaps_leonard]

@Ukraine Stand with the brave people of the Ukraine - every BTC counts!

[Leonard Kaps @kaps_leonard]

Hathor 101 by @trondbjoroy https://t.co/Uh6vxU6e0c

[Leonard Kaps @kaps_leonard]

Lass dich impfen!

[Leonard Kaps @kaps_leonard]

CAF as key target for antistromal therapy in liver cancer!

Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers https://t.co/ol4DRlbInl via @MDPIOpenAccess

[Leonard Kaps @kaps_leonard]

Symptom burden is significant in patients with PBC. Beside pruritus, fatigue was reported to be burdensome even though patients show an adequate biochemical response to UDCA!

https://t.co/RbWHthfrPZ

[Leonard Kaps @kaps_leonard]

#AASLD 2019 #Nanoparticles #posterpresentation #Bundeswehr

Nice work of Niklas Choteschovsky presented by the AASLD this year. Nanoparticlur Alendronte showed an antibiotic effect in CCl4 liver fibrotic mice

[Novartis News @NovartisNews]

A first of its kind public-private partnership with the Government of Ghana to improve the diagnosis and accelerate treatment for people with #sicklecell disease, including making medicine available to people diagnosed with the disease. Learn more: https://t.co/Im2gfBUwtr